Alemtuzumab for Multiple Sclerosis. (2016)

First Author: Willis MD
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11910-016-0685-y

PubMed Identifier: 27485945

Publication URI: http://europepmc.org/abstract/MED/27485945

Type: Journal Article/Review

Volume: 16

Parent Publication: Current neurology and neuroscience reports

Issue: 9

ISSN: 1528-4042